70710-1926Level 3
Sodium phenylacetate and Sodium benzoate (Sodium phenylacetate and Sodium benzoate)
**Product type:** Human Prescription Drug
**Active ingredient:** SODIUM BENZOATE; SODIUM PHENYLACETATE
**Strength:** 100; 100 mg/mL; mg/mL
**Dosage form:** Injection, Solution, Concentrate
**Route:** Intravenous
**Labeler:** Zydus Pharmaceuticals USA Inc.
**Marketing category:** ANDA (ANDA217526)
**Pharmacologic class:** Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC]
GET
/api/v1/systems/ndc_fda/nodes/70710-1926Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.